- Report
- February 2024
- 101 Pages
Global
From €3500EUR$4,131USD£3,054GBP
- Report
- April 2023
- 140 Pages
Global
From €4039EUR$4,450USD£3,405GBP
- Report
- April 2024
- 200 Pages
Global
From €2950EUR$3,250USD£2,487GBP
€4402EUR$4,850USD£3,711GBP
- Report
- August 2022
- 120 Pages
Global
From €4084EUR$4,500USD£3,443GBP
- Report
- July 2022
- 64 Pages
Global
From €1815EUR$2,000USD£1,530GBP
- Report
- May 2022
- 38 Pages
Global
From €1815EUR$2,000USD£1,530GBP
- Drug Pipelines
- March 2021
Global
From €2269EUR$2,500USD£1,913GBP
- Drug Pipelines
- November 2020
- 93 Pages
Global
From €1815EUR$2,000USD£1,530GBP
- Drug Pipelines
- October 2020
- 779 Pages
Global
From €1815EUR$2,000USD£1,530GBP
- Drug Pipelines
- October 2020
- 151 Pages
Global
From €1815EUR$2,000USD£1,530GBP
- Drug Pipelines
- August 2020
- 693 Pages
Global
From €1815EUR$2,000USD£1,530GBP
From €1901EUR$2,095USD£1,603GBP
€3621EUR$3,990USD£3,053GBP
- Report
- June 2025
United Kingdom
From €1901EUR$2,095USD£1,603GBP
€3621EUR$3,990USD£3,053GBP
- Drug Pipelines
- March 2023
- 125 Pages
Global
From €13609EUR$14,995USD£11,472GBP
- Report
- November 2022
- 103 Pages
Global
From €3585EUR$3,950USD£3,022GBP
- Report
- October 2021
- 78 Pages
Global
From €3630EUR$4,000USD£3,060GBP
- Report
- June 2022
- 90 Pages
Global
From €3630EUR$4,000USD£3,060GBP
- Report
- October 2023
- 300 Pages
Global
From €2269EUR$2,500USD£1,913GBP
- Report
- October 2023
- 80 Pages
United Kingdom
From €1361EUR$1,500USD£1,148GBP
From €1361EUR$1,500USD£1,148GBP

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more